---
figid: PMC7934064__10.1177_1179554921996288-fig2
figlink: pmc/articles/PMC7934064/figure/fig2-1179554921996288/
number: F2
caption: The mechanisms involved in DDR and checkpoint immunotherapies. (A) PARPi
  promote antigen presentation by ICD owing to the failure of DNA repair; (B) PARPi
  upregulate the release of Th1 cytokines and recruit CD4+CD8+ T cells via CCL5 and
  CXCL10; (C) PARPi promote T-cell infiltration; (D) PARPi increase PD-L1 expression
  by GSK-3β, ATM-ATR-CHK1, and cGAS-STING pathway; (E) PARPi regulate EMT; and (F)
  PARPi inhibit tumor angiogenesis by modulating PARP1/HIF1-α/VEGF signals.ATM indicates
  ataxia telangiectasia-mutated gene; ATR, ataxia telangiectasia and Rad3 related;
  CCL2, C-C motif chemokine ligand 2; CCL5, C-C motif chemokine ligand 5; cGAS, cyclic
  GMP-AMP synthase; CHEK1, checkpoint kinase 1; CXCL10, C-X-C motif chemokine ligand
  10; DAMP, damage-associated molecular pattern; DDR, DNA damage response; EMT, epithelial-mesenchymal
  transition; GSK-3β, glycogen synthase kinase-3β; HIF-1α, hypoxia-inducible factor-1
  α; HR, homologous recombination; ICD, immunogenic cell death; IL, interleukin; INF-g,
  interferon-γ; MHC I, major histocompatibility complex class I; NF-κB, nuclear factor-kB;
  NKG2D(L), natural killer cells group 2D (ligand); PARPi, poly (ADP-ribose) polymerase
  inhibitors; SSB, single-strand breaks; PD-L1, programmed-death ligand 1; STING,
  stimulator of interferon genes; TILs, tumor-infiltrating lymphocytes; VEGF, vascular
  endothelial growth factor; TCR, T cell receptor; mDC, myeloid dendritic cells.
pmcid: PMC7934064
papertitle: The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors.
reftext: Zhaozhen Wu, et al. Clin Med Insights Oncol. 2021;15:1179554921996288.
pmc_ranked_result_index: '113662'
pathway_score: 0.959242
filename: 10.1177_1179554921996288-fig2.jpg
figtitle: Mechanisms involved in DDR and checkpoint immunotherapies
year: '2021'
organisms:
- Mus musculus
- Human gammaherpesvirus 4
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7934064__10.1177_1179554921996288-fig2.html
  '@type': Dataset
  description: The mechanisms involved in DDR and checkpoint immunotherapies. (A)
    PARPi promote antigen presentation by ICD owing to the failure of DNA repair;
    (B) PARPi upregulate the release of Th1 cytokines and recruit CD4+CD8+ T cells
    via CCL5 and CXCL10; (C) PARPi promote T-cell infiltration; (D) PARPi increase
    PD-L1 expression by GSK-3β, ATM-ATR-CHK1, and cGAS-STING pathway; (E) PARPi regulate
    EMT; and (F) PARPi inhibit tumor angiogenesis by modulating PARP1/HIF1-α/VEGF
    signals.ATM indicates ataxia telangiectasia-mutated gene; ATR, ataxia telangiectasia
    and Rad3 related; CCL2, C-C motif chemokine ligand 2; CCL5, C-C motif chemokine
    ligand 5; cGAS, cyclic GMP-AMP synthase; CHEK1, checkpoint kinase 1; CXCL10, C-X-C
    motif chemokine ligand 10; DAMP, damage-associated molecular pattern; DDR, DNA
    damage response; EMT, epithelial-mesenchymal transition; GSK-3β, glycogen synthase
    kinase-3β; HIF-1α, hypoxia-inducible factor-1 α; HR, homologous recombination;
    ICD, immunogenic cell death; IL, interleukin; INF-g, interferon-γ; MHC I, major
    histocompatibility complex class I; NF-κB, nuclear factor-kB; NKG2D(L), natural
    killer cells group 2D (ligand); PARPi, poly (ADP-ribose) polymerase inhibitors;
    SSB, single-strand breaks; PD-L1, programmed-death ligand 1; STING, stimulator
    of interferon genes; TILs, tumor-infiltrating lymphocytes; VEGF, vascular endothelial
    growth factor; TCR, T cell receptor; mDC, myeloid dendritic cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NELFCD
  - IL2
  - PDCD1
  - IL6
  - CXCL8
  - CCL5
  - CD8A
  - CD8B
  - CXCL10
  - TRA
  - TRB
  - TRD
  - TRG
  - CD274
  - IL12A
  - IL12B
  - CCL22
  - ATR
  - TMEM173
  - CGAS
  - CHEK1
  - ATM
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - HIF1A
  - PARP1
  - KLRK1
  - PARP2
  - PARP3
  - TIPARP
  - PARP6
  - PARP8
  - PARP10
  - PARP15
  - PARP4
  - TNKS
  - PARP14
  - PARP16
  - PARP11
  - PARP12
  - TNKS2
  - PARP9
  - TCR
  - tumor
  - HR deficiency
genes:
- word: Th1
  symbol: TH1
  source: hgnc_alias_symbol
  hgnc_symbol: NELFCD
  entrez: '51497'
- word: IL-2
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: CCL5
  symbol: CCL5
  source: hgnc_symbol
  hgnc_symbol: CCL5
  entrez: '6352'
- word: CD8*
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: CD8*
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: CXCL10
  symbol: CXCL10
  source: hgnc_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: mDC
  symbol: MDC
  source: hgnc_alias_symbol
  hgnc_symbol: CCL22
  entrez: '6367'
- word: GSK-38ATM/ATR/CHEK1CGAS/STING
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: GSK-38ATM/ATR/CHEK1CGAS/STING
  symbol: STING
  source: hgnc_alias_symbol
  hgnc_symbol: TMEM173
  entrez: '340061'
- word: CGAS/STING
  symbol: STING
  source: hgnc_alias_symbol
  hgnc_symbol: TMEM173
  entrez: '340061'
- word: CGAS/STING
  symbol: CGAS
  source: hgnc_symbol
  hgnc_symbol: CGAS
  entrez: '115004'
- word: ATM/ATR/CHEK1
  symbol: CHEK1
  source: hgnc_symbol
  hgnc_symbol: CHEK1
  entrez: '1111'
- word: ATM/ATR/CHEK1
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: ATM/ATR/CHEK1
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: HIF-1a
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: PARP1
  symbol: PARP1
  source: hgnc_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: NKG2D
  symbol: NKG2D
  source: hgnc_alias_symbol
  hgnc_symbol: KLRK1
  entrez: '22914'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
diseases:
- word: tumor
  source: MESH
  identifier: D009369
- word: HR deficiency
  source: MESH
  identifier: D001919
figid_alias: PMC7934064__F2
redirect_from: /figures/PMC7934064__F2
figtype: Figure
---
